Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:1795-1801
Published online before print March 22, 2004, doi: 10.1161/01.CIR.0000124223.00113.A4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/14/1795    most recent
01.CIR.0000124223.00113.A4v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jung, O.
Right arrow Articles by Brandes, R.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jung, O.
Right arrow Articles by Brandes, R.P.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Oxidant stress
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 2004;109:1795-1801.)
© 2004 American Heart Association, Inc.


Basic Science Reports

gp91phox-Containing NADPH Oxidase Mediates Endothelial Dysfunction in Renovascular Hypertension

O. Jung, MD; J.G. Schreiber; H. Geiger, MD; T. Pedrazzini, MD; R. Busse, MD; R.P. Brandes, MD

From the Institut für Kardiovaskuläre Physiologie (O.J., J.G.S., R.B., R.P.B.) and Medizinische Klinik IV, Funktionsbereich Nephrologie (H.G.), Klinikum der J.W. Goethe-Universität, Frankfurt am Main, Germany, and the Division of Hypertension, University of Lausanne Medical School, Lausanne, Switzerland (T.P.).

Correspondence to Ralf P. Brandes, MD, Institut für Kardiovaskuläre Physiologie, Klinikum der J.W. Goethe-Universität, Theodor-Stern-Kai 7, D-60596 Frankfurt am Main, Germany. E-mail r.brandes{at}em.uni-frankfurt.de

Received June 16, 2003; de novo received November 6, 2003; accepted January 5, 2004.

Background— Isoforms of the NADPH oxidase contribute to vascular superoxide anion ( · O2) formation and limit NO bioavailability. We hypothesized that the endothelial gp91phox-containing NADPH oxidase is predominant in generating the O2 to scavenge endothelial NO and thus is responsible for the development of endothelial dysfunction.

Methods and Results— Endothelial dysfunction was studied in aortic rings from wild-type (WT) and gp91phox-knockout (gp91phox–/–) mice with and without renovascular hypertension induced by renal artery clipping (2K1C). Hypertension induced by 2K1C was more severe in WT than in gp91phox–/– mice (158±2 versus 149±2 mm Hg; P<0.05). Endothelium-dependent relaxation to acetylcholine (ACh) was attenuated in rings from clipped WT but not from clipped gp91phox–/– mice. The reactive oxygen species (ROS) scavenger Tiron, PEG-superoxide dismutase, and the NADPH oxidase inhibitory peptide gp91ds-tat enhanced ACh-induced relaxation in aortae of clipped WT mice. Inhibition of protein kinase C, Rac, and the epidermal growth factor receptor kinase, elements involved in the activation of the NADPH oxidase, restored normal endothelium-dependent relaxation in vessels from clipped WT mice but had no effect on relaxations in those from gp91phox–/– mice. Relaxations to exogenous NO were attenuated in vessels from clipped WT but not clipped gp91phox–/– mice. After removal of the endothelium or treatment with PEG-superoxide dismutase, NO-induced relaxations were identical in vessels from clipped and sham-operated WT and gp91phox mice.

Conclusions— These data indicate that the formation of O2 by the endothelial gp91phox-containing NADPH oxidase accounts for the reduced NO bioavailability in the 2K1C model and contributes to the development of renovascular hypertension and endothelial dysfunction.


Key Words: stress, oxidative • angiotensin • endothelium • hypertension




This article has been cited by other articles:


Home page
JEMHome page
A. E. Loot, J. G. Schreiber, B. Fisslthaler, and I. Fleming
Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase
J. Exp. Med., November 23, 2009; (2009) jem.20090449v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. T. Jenkins, S. Witkowski, E. E. Spangenburg, and J. M. Hagberg
Effects of acute and chronic endurance exercise on intracellular nitric oxide in putative endothelial progenitor cells: role of NAPDH oxidase
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1798 - H1805.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Violi, V. Sanguigni, R. Carnevale, A. Plebani, P. Rossi, A. Finocchi, C. Pignata, D. De Mattia, B. Martire, M. C. Pietrogrande, et al.
Hereditary Deficiency of gp91phox Is Associated With Enhanced Arterial Dilatation: Results of a Multicenter Study
Circulation, October 20, 2009; 120(16): 1616 - 1622.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Xu, S. Wang, Y. Wu, P. Song, and M.-H. Zou
Tyrosine Nitration of PA700 Activates the 26S Proteasome to Induce Endothelial Dysfunction in Mice With Angiotensin II-Induced Hypertension
Hypertension, September 1, 2009; 54(3): 625 - 632.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. J. Ryan
Young Investigator Award Lecture of the APS Water and Electrolyte Homeostasis Section, 2008: The pathophysiology of hypertension in systemic lupus erythematosus
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R1258 - R1267.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Carlstrom, E. Y. Lai, Z. Ma, A. Patzak, R. D. Brown, and A. E. G. Persson
Role of NOX2 in the regulation of afferent arteriole responsiveness
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2009; 296(1): R72 - R79.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Q. Zhang, P. Malik, D. Pandey, S. Gupta, D. Jagnandan, E. B. de Chantemele, B. Banfi, M. B. Marrero, R. D. Rudic, D. W. Stepp, et al.
Paradoxical Activation of Endothelial Nitric Oxide Synthase by NADPH Oxidase
Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1627 - 1633.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
T. M. Paravicini and R. M. Touyz
NADPH Oxidases, Reactive Oxygen Species, and Hypertension: Clinical implications and therapeutic possibilities
Diabetes Care, February 1, 2008; 31(Supplement_2): S170 - S180.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. I. Schrader, D. A. Kinzenbaw, A. W. Johnson, F. M. Faraci, and S. P. Didion
IL-6 Deficiency Protects Against Angiotensin II Induced Endothelial Dysfunction and Hypertrophy
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2576 - 2581.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
V. A. Korshunov, M. Daul, M. P. Massett, and B. C. Berk
Axl Mediates Vascular Remodeling Induced by Deoxycorticosterone Acetate Salt Hypertension
Hypertension, December 1, 2007; 50(6): 1057 - 1062.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Kahles, P. Luedike, M. Endres, H.-J. Galla, H. Steinmetz, R. Busse, T. Neumann-Haefelin, and R. P. Brandes
NADPH Oxidase Plays a Central Role in Blood-Brain Barrier Damage in Experimental Stroke
Stroke, November 1, 2007; 38(11): 3000 - 3006.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C.-C. Yang, M.-C. Ma, C.-T. Chien, M.-S. Wu, W.-K. Sun, and C.-F. Chen
Hypoxic preconditioning attenuates lipopolysaccharide-induced oxidative stress in rat kidneys
J. Physiol., July 1, 2007; 582(1): 407 - 419.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. K. Bendall, R. Rinze, D. Adlam, A. L. Tatham, J. de Bono, and K. M. Channon
Endothelial Nox2 Overexpression Potentiates Vascular Oxidative Stress and Hemodynamic Response to Angiotensin II: Studies in Endothelial-Targeted Nox2 Transgenic Mice
Circ. Res., April 13, 2007; 100(7): 1016 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Violi, V. Sanguigni, L. Loffredo, R. Carnevale, B. Buchetti, A. Finocchi, M. Tesauro, P. Rossi, and P. Pignatelli
Nox2 is determinant for ischemia-induced oxidative stress and arterial vasodilatation: a pilot study in patients with hereditary Nox2 deficiency.
Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): e131 - e132.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. M. Paravicini and R. M. Touyz
Redox signaling in hypertension
Cardiovasc Res, July 15, 2006; 71(2): 247 - 258.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Nakano, C.-J. Kwak, K. Fujii, K. Ikemura, A. Satake, M. Ohkita, M. Takaoka, Y. Ono, M. Nakai, N. Tomimori, et al.
Sesamin Metabolites Induce an Endothelial Nitric Oxide-Dependent Vasorelaxation through Their Antioxidative Property-Independent Mechanisms: Possible Involvement of the Metabolites in the Antihypertensive Effect of Sesamin
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 328 - 335.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J.-S. Wang, H. Singh, F. Zhang, T. Ishizuka, H. Deng, R. Kemp, M. S. Wolin, T. H. Hintze, N. G. Abraham, A. Nasjletti, et al.
Endothelial Dysfunction and Hypertension in Rats Transduced With CYP4A2 Adenovirus
Circ. Res., April 14, 2006; 98(7): 962 - 969.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. L. Hordijk
Regulation of NADPH Oxidases: The Role of Rac Proteins
Circ. Res., March 3, 2006; 98(4): 453 - 462.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
D. M. Browe and C. M. Baumgarten
EGFR Kinase Regulates Volume-sensitive Chloride Current Elicited by Integrin Stretch via PI-3K and NADPH Oxidase in Ventricular Myocytes
J. Gen. Physiol., February 27, 2006; 127(3): 237 - 251.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. P. Didion, D. A. Kinzenbaw, and F. M. Faraci
Critical Role for CuZn-Superoxide Dismutase in Preventing Angiotensin II-Induced Endothelial Dysfunction
Hypertension, November 1, 2005; 46(5): 1147 - 1153.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. Zhan, F. Serrano, P. Fenik, R. Hsu, L. Kong, D. Pratico, E. Klann, and S. C. Veasey
NADPH Oxidase Mediates Hypersomnolence and Brain Oxidative Injury in a Murine Model of Sleep Apnea
Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 921 - 929.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Kinugawa, J. Zhang, E. Messina, E. Walsh, H. Huang, P. M. Kaminski, M. S. Wolin, and T. H. Hintze
gp91phox-containing NAD(P)H oxidase mediates attenuation of nitric oxide-dependent control of myocardial oxygen consumption by ANG II
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H862 - H867.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. C. Bowers, K. A. Katki, A. Rao, M. Koehler, P. Patel, A. Spiekerman, D. J. DiPette, and S. C. Supowit
Role of Calcitonin Gene-Related Peptide in Hypertension-Induced Renal Damage
Hypertension, July 1, 2005; 46(1): 51 - 57.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. P. Brandes, I. Fleming, and R. Busse
Endothelial aging
Cardiovasc Res, May 1, 2005; 66(2): 286 - 294.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. M. Touyz, C. Mercure, Y. He, D. Javeshghani, G. Yao, G. E. Callera, A. Yogi, N. Lochard, and T. L. Reudelhuber
Angiotensin II-Dependent Chronic Hypertension and Cardiac Hypertrophy Are Unaffected by gp91phox-Containing NADPH Oxidase
Hypertension, April 1, 2005; 45(4): 530 - 537.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. Adams, A. Linke, N. Krankel, S. Erbs, S. Gielen, S. Mobius-Winkler, J. F. Gummert, F. W. Mohr, G. Schuler, and R. Hambrecht
Impact of Regular Physical Activity on the NAD(P)H Oxidase and Angiotensin Receptor System in Patients With Coronary Artery Disease
Circulation, February 8, 2005; 111(5): 555 - 562.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. P. Brandes and J. Kreuzer
Vascular NADPH oxidases: molecular mechanisms of activation
Cardiovasc Res, January 1, 2005; 65(1): 16 - 27.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Wassmann, T. Czech, M. van Eickels, I. Fleming, M. Bohm, and G. Nickenig
Inhibition of Diet-Induced Atherosclerosis and Endothelial Dysfunction in Apolipoprotein E/Angiotensin II Type 1A Receptor Double-Knockout Mice
Circulation, November 9, 2004; 110(19): 3062 - 3067.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Park, J. Anrather, P. Zhou, K. Frys, G. Wang, and C. Iadecola
Exogenous NADPH Increases Cerebral Blood Flow Through NADPH Oxidase-Dependent and -Independent Mechanisms
Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1860 - 1865.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. P. Brandes
And What About the Endothelium?: On the Predominance of Cerebral Superoxide Formation for Angiotensin II-Induced Systemic Hypertension
Circ. Res., July 23, 2004; 95(2): 122 - 124.
[Full Text] [PDF]